Yong'an Ye
Beijing, 100700, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Gene-predicted Causal Association of Immune Cell-mediated Plasma Metabolites with Acute Hepatitis B: A Mendelian Randomization Study.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: August 16, 2025
Interpretation of the Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Liver Cirrhosis
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: November 19, 2024
JiGuCao capsule formula alleviates metabolic fatty liver disease by regulating the gut-liver axis and lipid metabolism.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 17, 2024
Downregulation of ST6GAL2 Correlates to Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma.
Journal: Journal of inflammation research
Published: November 10, 2023
Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: April 04, 2023
Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and in vivo/vitro experiment verification.
Journal: Frontiers in pharmacology
Published: February 05, 2023
Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model.
Journal: Frontiers in public health
Published: January 04, 2023
Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study.
Journal: Frontiers in genetics
Published: November 29, 2022
Is it possible to intervene early cirrhosis by targeting toll-like receptors to rebalance the intestinal microbiome?
Journal: International immunopharmacology
Published: November 01, 2022
Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis.
Journal: Frontiers in public health
Published: September 07, 2022
Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma.
Journal: Journal of inflammation research
Published: August 12, 2022
Last Updated: 09/26/2026